强化降脂治疗下颅内动脉粥样硬化性狭窄的血管外壁回缩与卒中复发
本研究基于中国多中心队列及机构数据库,分析首次急性缺血性卒中归因于颅内动脉粥样硬化性狭窄并接受强化降脂治疗的患者,基线与随访>6个月行3D T1加权高分辨磁共振血管壁成像,评估外壁边界面积变化与同侧卒中复发的关联。结果显示外壁回缩与卒中复发风险显著升高相关。
要点
- 强化降脂下外壁边界面积变化分为扩张、回缩和静止,回缩占29.2%。
- 外壁回缩患者同侧卒中复发风险显著高于无回缩者(HR 2.95)。
- 多变量校正后外壁回缩仍与复发独立相关(HR 4.21)。
核心结论
- 强化降脂治疗下颅内动脉粥样硬化性狭窄患者的外壁边界面积变化存在异质性,外壁回缩与同侧卒中复发风险升高显著相关。
研究设计与样本
- 多中心队列研究,纳入中国15家医院及北京机构数据库中首次急性缺血性卒中归因于颅内动脉粥样硬化性狭窄并接受强化降脂治疗(高剂量他汀或PCSK9i)的患者137例。
- 所有患者在基线和>6个月随访时接受3D T1加权高分辨磁共振血管壁成像,外壁边界面积变化分为扩张(>10%增加)、回缩(>10%减少)或静止(≤10%变化)。
主要发现
- 137例患者中,50例(36.5%)外壁扩张,40例(29.2%)回缩,47例(34.3%)静止。
- 三组斑块负荷从基线到随访均显著下降(所有P≤0.02)。
- 外壁扩张组(P<0.001)和静止组(P=0.01)管腔面积显著增加,回缩组无显著增加(P=0.34)。
- 外壁回缩患者同侧卒中复发风险显著高于无回缩者(HR 2.95 [95% CI 1.02-8.55],P=0.046)。
- 多变量Cox回归校正潜在混杂因素后,外壁回缩仍与同侧卒中复发相关(HR 4.21 [95% CI 1.14-15.58],P=0.031)。
临床怎么用
- 强化降脂治疗期间可通过高分辨磁共振血管壁成像评估外壁边界变化,外壁回缩或提示卒中复发高风险,需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the dynamic process of the outer-wall boundary during intensive lipid-lowering therapy in patients with intracranial atherosclerotic stenosis and its clinical implications. METHODS: We analyzed patients with first-ever acute ischemic stroke attributed to intracranial atherosclerotic stenosis who received intensive lipid-lowering therapy with high-dose statins or PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitor). Data were obtained from a multicenter cohort study at 15 hospitals across China and our institutional database in Beijing, China. All patients underwent 3-dimensional T1-weighted high-resolution magnetic resonance vessel wall imaging at baseline and after a >6-month follow-up period. Outer-wall boundary area changes were classified as expansion (>10% increase), shrinkage (>10% decrease), or quiescence (≤10% change). The association between these changes and time to recurrent ipsilateral stroke was assessed. The Kaplan-Meier method and the Cox proportional hazards model were used. RESULTS: Among the 137 patients, 50 (36.5%) exhibited expansion, 40 (29.2%) shrinkage, and 47 (34.3%) quiescence of the outer-wall boundary area. Among these 3 groups, plaque burden decreased significantly between the index imaging and follow-up (all P≤0.02). Lumen area increased significantly in patients with expansion (P<0.001) and quiescence (P=0.01) but not in those with shrinkage of the outer-wall boundary area (P=0.34). Patients with shrinkage of the outer-wall boundary area had a significantly increased risk of recurrent ipsilateral stroke (hazard ratio, 2.95 [95% CI, 1.02-8.55]; P=0.046) compared with patients without such shrinkage. In multivariable Cox regression analysis, shrinkage of the outer-wall boundary area was associated with recurrent ipsilateral stroke compared with non-shrinkage after adjusting for potential confounders (hazard ratio, 4.21 [95% CI, 1.14-15.58]; P=0.031). CONCLUSIONS: Outer-wall boundary area changes vary among patients with intracranial atherosclerotic stenosis under intensive lipid-lowering therapy. Shrinkage of the outer-wall boundary area is significantly associated with a higher risk of stroke recurrence.
引用
- Yuan W, Yan Z, Lu B, et al. Vessel Shrinkage and Stroke Recurrence in Intracranial Atherosclerotic Stenosis Under Intensive Lipid-Lowering Therapy. Stroke. 2025. PMID: 40832711. doi:10.1161/STROKEAHA.125.051719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。